Takeda Pharmaceutical Company Limited NYQ · TAK

[Latest] Global Botulinum Toxin in Urology Market Size/Share Worth USD 1.98 Billion by 2035 at a 6.08% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire Inc. · 17h ago

Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 | Benchmark More Than 1,800 Biopharma Deals with Various Indexes

GlobeNewswire Inc. · 6d ago

Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider

GlobeNewswire Inc. · 7d ago

Takeda AI-Drug Shows Superior Skin Clearance Against Bristol-Myers' Med

Benzinga · 41d ago

Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026

GlobeNewswire Inc. · 52d ago

Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026

GlobeNewswire Inc. · 52d ago

Tacrolimus Market Research Report 2026: Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2035

GlobeNewswire Inc. · 59d ago

Jury Hits Takeda With $885 Million Antitrust Verdict

Benzinga · 64d ago

Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsight

GlobeNewswire Inc. · 78d ago

IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight

GlobeNewswire Inc. · 84d ago

Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight

GlobeNewswire Inc. · 91d ago

Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight

GlobeNewswire Inc. · 97d ago

The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight

GlobeNewswire Inc. · 99d ago

Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight

GlobeNewswire Inc. · 100d ago

Crohn's Disease Eight-Market Drug Forecast and Market Analysis Report 2025-2026: Novel MOAs Will Provide Market Shifts Throughout the Forecast Period to 2032

GlobeNewswire Inc. · 104d ago

Takeda Exits Dementia Drug Partnership With Denali Therapeutics - Here's Why

Benzinga · 107d ago

What's Going On With Eli Lilly On Monday?

Benzinga · 121d ago

Feiba VH (Takeda Pharmaceuticals) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F

GlobeNewswire Inc. · 134d ago

Takeda Shares Down After Entyvio Shows Strong Results In Ulcerative Colitis Trial In Children, Shows Potential To Address Treatment Gaps

Benzinga · 152d ago

Global Blood Plasma Derivatives Market Size Projected to Reach $104.30 Billion by 2033; Immunoglobulins Drive Robust 9.08% CAGR – SNS Insider

GlobeNewswire Inc. · 154d ago

FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer

Benzinga · 154d ago

Anti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management

GlobeNewswire Inc. · 167d ago

Takeda Flags Vyvanse Hit, Lifts 2025 Profit Guidance On Cost Control

Benzinga · 174d ago

COUR Pharma Publishes Peer-Reviewed Data in Science Advances

GlobeNewswire Inc. · 175d ago

Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle

Benzinga · 176d ago